loading...| Preferred Name | Betamethasone | |
| Synonyms |
|
|
| Definitions |
A synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory activities. Betamethasone binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C303 |
|
| CAS_Registry |
378-44-9 |
|
| CHEBI_ID |
CHEBI:3077 |
|
| Chemical_Formula |
C22H29FO5 |
|
| code |
C303 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory activities. Betamethasone binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. |
|
| FDA_UNII_Code |
9842X06Q6M |
|
| in_subset | ||
| label |
Betamethasone |
|
| Legacy Concept Name |
Betamethasone |
|
| NCI_Drug_Dictionary_ID |
39273 |
|
| NSC Number |
39470 |
|
| PDQ_Closed_Trial_Search_ID |
39273 |
|
| PDQ_Open_Trial_Search_ID |
39273 |
|
| Preferred_Name |
Betamethasone |
|
| prefixIRI |
NCIT:C303 |
|
| prefLabel |
Betamethasone |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0005308 |
|
| subClassOf |